AI x Bio Summit: Co-Founder Transon Nguyen describes how AI is enabling Eigen Therapeutics to become a discovery engine for priming therapies
He explains how the goal of Eigen is to help up-regulate antigens of interest and how technologies today allow a smaller startup to derive and test large datasets.